EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,867,000 | +7.4% | 117,275 | +4.3% | 0.25% | -9.1% |
| Q2 2020 | $2,669,000 | +397.9% | 112,445 | +311.9% | 0.27% | +878.6% |
| Q4 2018 | $536,000 | +142.5% | 27,300 | +118.4% | 0.03% | +250.0% |
| Q3 2018 | $221,000 | -86.3% | 12,500 | -76.4% | 0.01% | -66.7% |
| Q4 2017 | $1,611,000 | -70.8% | 53,000 | -76.3% | 0.02% | -71.1% |
| Q2 2017 | $5,517,000 | +69.5% | 224,000 | +49.1% | 0.08% | +69.4% |
| Q1 2017 | $3,254,000 | +999.3% | 150,200 | +295.3% | 0.05% | +250.0% |
| Q2 2016 | $296,000 | -64.5% | 38,000 | -81.8% | 0.01% | -65.0% |
| Q1 2016 | $834,000 | +62.3% | 208,600 | +128.7% | 0.04% | +29.0% |
| Q4 2015 | $514,000 | +188.8% | 91,200 | +31.4% | 0.03% | +82.4% |
| Q1 2015 | $178,000 | +278.7% | 69,400 | +110.9% | 0.02% | +142.9% |
| Q4 2014 | $47,000 | -2.1% | 32,900 | +4.4% | 0.01% | -22.2% |
| Q3 2014 | $48,000 | -92.2% | 31,500 | -81.9% | 0.01% | -69.0% |
| Q1 2014 | $614,000 | +859.4% | 173,600 | +1464.0% | 0.03% | +383.3% |
| Q3 2013 | $64,000 | – | 11,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |